SCHEMBL975343

SCHEMBL975343

CC(=O)c1ccc2c(C)c3ccccc3c(C)c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
MAPT P10636 4/20 0.59
HPGD P15428 3/20 0.59
NPC1 O15118 3/20 0.51
RAB9A P51151 2/20 0.51
KIF11 P52732 1/20 0.47
S100A4 P26447 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
APAF1 O14727 1/20 0.44
CYP2A6 P11509 1/20 0.44
KDM4E B2RXH2 2/20 0.44
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.41
GUSB P08236 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29780395 1.00 ALDH1A1 (0.59) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL15040996 0.85 KIF11 (0.51) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL10023267 0.85 ALDH1A1 (0.66) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL978869 0.84 KDM4E (0.59) ALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL20313052 0.83 KIF11 (0.44) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL23169789 0.80 HPGD (0.44) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL15040959 0.80 ATM (0.43) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL15041011 0.80 CES2 (0.48) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL976725 0.79 KIF11 (0.59) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL10484226 0.77 ALDH1A1 (0.83) ALDH1A1MAPTHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114752374-B Preparation method of microsphere composition used for homogeneous phase chemiluminescence immunoassay technology 北京艾维镝生物技术有限责任公司 2023-02-03 CN claimed
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 US disclosed
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2025-07-17 US disclosed
US-12285250-B2 Near-IR glucose sensors PROFUSA, INC (US) 2025-04-29 US disclosed
WO-2023085617-A1 STRUCTURE COMPRISING ANTHRACENEDIBORONIC ACID-BASED COMPOUND FOR DETECTING GLUCOSE, PREPARATION METHOD THEREFOR, AND USE THEREOF 재단법인 대구경북첨단의료산업진흥재단 2023-05-19 WO disclosed
CN-114752374-B Preparation method of microsphere composition used for homogeneous phase chemiluminescence immunoassay technology 北京艾维镝生物技术有限责任公司 2023-02-03 CN disclosed
CN-113683631-B Organic boric acid glucose probe and preparation method and application thereof 王凯 2023-01-17 CN disclosed
CN-114752374-A Preparation method of microsphere composition used in homogeneous chemiluminescence immunoassay technology 北京艾维镝生物技术有限责任公司 2022-07-15 CN disclosed
CN-113683631-A Organic boric acid glucose probe and preparation method and application thereof 王凯 2021-11-23 CN disclosed
US-20210101915-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2021-04-08 US disclosed
CN-1900212-B Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO CORP 2012-04-25 CN disclosed
US-7873398-B2 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2011-01-18 US disclosed
US-7524985-B2 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2009-04-28 US disclosed
US-20080319288-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2008-12-25 US disclosed
US-7388110-B2 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2008-06-17 US disclosed
US-20080021236-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2008-01-24 US disclosed
EP-1619229-B1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO CORP (JP) 2007-04-11 EP disclosed
CN-1900212-A Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO CORP (JP) 2007-01-24 CN disclosed
US-20060020182-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA 2006-01-26 US disclosed
EP-1619229-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor TERUMO KABUSHIKI KAISHA (JP) 2006-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 ALDH1A1 3159/4885MAPT 1631/4885HPGD 3387/4885
US-20210101915-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 ALDH1A1 3159/4885MAPT 1631/4885HPGD 3387/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 ALDH1A1 3198/4885MAPT 935/4885HPGD 4462/4885
US-20080319288-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor ACMSD, QPCT, B3GNT2 ALDH1A1 167/4885MAPT 4815/4885HPGD 442/4885
US-12285250-B2 Near-IR glucose sensors IRS1, SLC2A4, GPR119 ALDH1A1 1177/4885MAPT 2198/4885HPGD 2318/4885
US-20060020182-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor ACMSD, QPCT, B3GNT2 ALDH1A1 273/4885MAPT 4783/4885HPGD 632/4885
US-20080021236-A1 Saccharide-measuring fluorescent monomer, saccharide-measuring fluorescent sensor substance, and implantable, saccharide-measuring sensor ACMSD, QPCT, B3GNT2 ALDH1A1 273/4885MAPT 4783/4885HPGD 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.